Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts

Conclusions
The study found no apparent sex-specific differences in survival or stroke in this trial of TAVR. This may reflect the changing demographic of patients enrolled, use of newer-generation valves with more sizes available, and more accurate valve sizing techniques.

Source: Journal of the American College of Cardiology: Cardiovascular Interventions - January 1, 2018 Category: Cardiology Authors: Szerlip, M., Gualano, S., Holper, E., Squiers, J. J., White, J. M., Doshi, D., Williams, M. R., Hahn, R. T., Webb, J. G., Svensson, L. G., Kirtane, A. J., Cohen, D. J., Douglas, P. S., Alu, M. C., Crowley, A., Tuzcu, E. M., Makkar, R. R., Herrmann, H. C., Tags: Focus on Cardiovascular Outcomes Among Women Source Type: research